GE Healthcare of Chalfont St. Giles, U.K., today begins its cash tender offer to acquire advanced oncology testing and diagnostic services firm Clarient of Aliso Viejo, CA.
GE is offering $5 per share for Clarient common stock and $20 per share for preferred stock, making the total transaction worth approximately $570 million.
GE today plans to file its tender offer statement with the U.S. Securities and Exchange Commission (SEC), while Clarient files a solicitation/recommendation statement that includes Clarient's board of directors' recommendation that its stockholders accept GE's offer.
The tender offer will expire at midnight EST on December 6, unless extended.
Related Reading
GE wins 7T Wis. MRI contract, November 5, 2010
GE inks consulting deal with West Physics, November 4, 2010
GE shows MRI options, software at ASTRO, November 3, 2010
GE gets FDA nod for new Vivid E9, November 1, 2010
GE, UPMC test digital pathology, October 28, 2010
Copyright © 2010 AuntMinnie.com
